Paul A Volberding

Summary

Country: USA

Publications

  1. ncbi request reprint Initiating HIV therapy. Timing is critical, controversial
    Paul A Volberding
    University of California, San Francisco, School of Medicine, UCSF Gladstone Institute of Virology and Immunology Center for AIDS Research, San Francisco Veterans Affairs Medical Center, USA
    Postgrad Med 115:15-8, 21, 24-6. 2004
  2. ncbi request reprint The impact of anemia on quality of life in human immunodeficiency virus-infected patients
    Paul Volberding
    Medical Service, University of California, San Francisco Veterans Affairs Medical Center, San Francisco, California 94121, CA
    J Infect Dis 185:S110-4. 2002
  3. ncbi request reprint Anemia in HIV infection: clinical impact and evidence-based management strategies
    Paul A Volberding
    University of California, San Francisco, CA, USA
    Clin Infect Dis 38:1454-63. 2004
  4. ncbi request reprint HIV therapy in 2003: consensus and controversy
    Paul A Volberding
    University of California, San Francisco, California 94121, USA
    AIDS 17:S4-11. 2003
  5. ncbi request reprint Opportunities and options for treatment research in resource-constrained settings
    Paul A Volberding
    University of California San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, CA 94121, USA
    Clin Infect Dis 37:S1-3. 2003
  6. doi request reprint Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease
    Andy I Choi
    Department of Medicine, San Francisco General Hospital, San Francisco, CA 94110, USA
    Clin Infect Dis 45:1633-9. 2007
  7. doi request reprint Long-term clinical consequences of acute kidney injury in the HIV-infected
    Andy I Choi
    Department of Medicine, San Francisco VA Medical Center, 4150 Clement Street, San Francisco, CA 94121, USA
    Kidney Int 78:478-85. 2010
  8. pmc Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons
    Andy I Choi
    Department of Medicine, San Francisco Veterans Affairs Medical Center, and University of California, San Francisco, USA
    Circulation 121:651-8. 2010
  9. ncbi request reprint A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy
    Jacob P Lalezari
    Quest Clinical Research, San Francisco, CA 94115, USA
    AIDS 17:691-8. 2003
  10. pmc Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment
    Paul Volberding
    University of California San Francisco, 4150 Clement Street, San Francisco, CA 94121, USA
    AIDS 23:1987-95. 2009

Research Grants

  1. UCSF-GIVI CENTER FOR AIDS RESEARCH
    Paul Volberding; Fiscal Year: 2007

Detail Information

Publications25

  1. ncbi request reprint Initiating HIV therapy. Timing is critical, controversial
    Paul A Volberding
    University of California, San Francisco, School of Medicine, UCSF Gladstone Institute of Virology and Immunology Center for AIDS Research, San Francisco Veterans Affairs Medical Center, USA
    Postgrad Med 115:15-8, 21, 24-6. 2004
    ..In this article, Dr Volberding addresses the central questions surrounding antiretroviral treatment initiation and reviews some available treatment options...
  2. ncbi request reprint The impact of anemia on quality of life in human immunodeficiency virus-infected patients
    Paul Volberding
    Medical Service, University of California, San Francisco Veterans Affairs Medical Center, San Francisco, California 94121, CA
    J Infect Dis 185:S110-4. 2002
    ..The purpose of this article is to describe the effects of anemia on QOL and to provide an overview of several studies showing that QOL improves with the alleviation of anemia...
  3. ncbi request reprint Anemia in HIV infection: clinical impact and evidence-based management strategies
    Paul A Volberding
    University of California, San Francisco, CA, USA
    Clin Infect Dis 38:1454-63. 2004
    ....
  4. ncbi request reprint HIV therapy in 2003: consensus and controversy
    Paul A Volberding
    University of California, San Francisco, California 94121, USA
    AIDS 17:S4-11. 2003
    ..The present review will address both the striking advantages of HIV therapy as well as the ongoing challenges in its application...
  5. ncbi request reprint Opportunities and options for treatment research in resource-constrained settings
    Paul A Volberding
    University of California San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, CA 94121, USA
    Clin Infect Dis 37:S1-3. 2003
    ..On the other hand, ones with a more observational design or that compare cohort experiences may well be feasible and able to provide information important in those settings, as well as in regions with abundant financial resources...
  6. doi request reprint Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease
    Andy I Choi
    Department of Medicine, San Francisco General Hospital, San Francisco, CA 94110, USA
    Clin Infect Dis 45:1633-9. 2007
    ....
  7. doi request reprint Long-term clinical consequences of acute kidney injury in the HIV-infected
    Andy I Choi
    Department of Medicine, San Francisco VA Medical Center, 4150 Clement Street, San Francisco, CA 94121, USA
    Kidney Int 78:478-85. 2010
    ..Additionally, AKI affected almost one of six patients with HIV who survived at least 90 days following discharge...
  8. pmc Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons
    Andy I Choi
    Department of Medicine, San Francisco Veterans Affairs Medical Center, and University of California, San Francisco, USA
    Circulation 121:651-8. 2010
    ..We examined the association between longitudinal measures of kidney function and albuminuria with risk of atherosclerotic CVD and heart failure in a contemporary cohort of HIV-infected individuals...
  9. ncbi request reprint A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy
    Jacob P Lalezari
    Quest Clinical Research, San Francisco, CA 94115, USA
    AIDS 17:691-8. 2003
    ..Secondary objectives included the determination of enfuvirtide pharmacokinetics and antiviral activity and the immunological response to the enfuvirtide-containing regimen...
  10. pmc Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment
    Paul Volberding
    University of California San Francisco, 4150 Clement Street, San Francisco, CA 94121, USA
    AIDS 23:1987-95. 2009
    ..Antiretroviral therapy in early HIV infection may enhance outcome and viral control may be better in acute versus recent infection 24 weeks after treatment interruption...
  11. doi request reprint Antiretroviral therapy and management of HIV infection
    Paul A Volberding
    Department of Medicine, University of California San Francisco, San Francisco, CA 94121, USA
    Lancet 376:49-62. 2010
    ....
  12. ncbi request reprint Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects
    Caroline M Behler
    Department of Hematology and Oncology, University of California San Francisco, San Francisco, CA 94143 1270, USA
    Clin Infect Dis 44:1375-83. 2007
    ....
  13. ncbi request reprint Adherence, resistance, and timing: current issues in the use of new therapies
    Paul Volberding
    Department of Medicine, University of California, San Francisco, USA
    AIDS Read 12:349-50, 356-7, 368. 2002
    ..Because adherence is linked to convenience and tolerability, new agents with favorable safety profiles, low pill burdens, and little or no selection for drug resistance will be required to ensure long-term viral suppression...
  14. ncbi request reprint Anemia and HIV in the antiretroviral era: potential significance of testosterone
    Caroline Behler
    Department of Medicine, San Francisco Veterans Affairs Medical Center, University of California San Francisco, San Francisco, California 94143, USA
    AIDS Res Hum Retroviruses 21:200-6. 2005
    ..20, 95% CI 0.05-0.84), and macrocytosis (adjusted OR 0.23, 95% CI 0.09-0.61). Low testosterone levels may have a positive association and supplemental androgens a negative association with anemia in HIV disease...
  15. ncbi request reprint Racial differences in end-stage renal disease rates in HIV infection versus diabetes
    Andy I Choi
    Department of Medicine, San Francisco General Hospital, San Francisco, CA 94110, USA
    J Am Soc Nephrol 18:2968-74. 2007
    ..HIV and diabetes carry a similar risk of ESRD among black patients, highlighting the importance of developing strategies to prevent and treat renal disease among HIV-infected black individuals...
  16. ncbi request reprint The pavia consensus statement
    Paul A Volberding
    University of California, San Francisco, USA
    AIDS 17:S170-9. 2003
  17. ncbi request reprint Introduction: the importance of identifying and treating complications of human immunodeficiency virus disease
    Paul Volberding
    University of California, San Francisco, Veterans Affairs Medical Center, San Francisco, California, USA
    J Infect Dis 185:S103-4. 2002
  18. doi request reprint Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel
    Scott M Hammer
    Division of Infectious Diseases, Columbia University College of Physicians and Surgeons, 630 W 168th St, New York, NY 10032, USA
    JAMA 300:555-70. 2008
    ....
  19. ncbi request reprint Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel
    Scott M Hammer
    Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    JAMA 296:827-43. 2006
    ..The International AIDS Society-USA panel has updated its recommendations as warranted by new developments in the field...
  20. ncbi request reprint Epoetin alfa for treatment of anemia in HIV-infected patients: past, present, and future
    David H Henry
    Department of Oncology, Hematology, Pennsylvania Hospital, Philadelphia, PA 19106, USA
    J Acquir Immune Defic Syndr 37:1221-7. 2004
    ..Current and future research will further clarify the role of epoetin alfa in the clinical management of the HIV-infected population...
  21. ncbi request reprint Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel
    Patrick G Yeni
    Department of Infectious Diseases, Hopital Bichat Claude Bernard, X Bichat Medical School, Paris, France
    JAMA 292:251-65. 2004
    ..Substantial changes in the field of human immunodeficiency virus (HIV) treatment have occurred in the last 2 years, prompting revision of the guidelines for antiretroviral management of adults with established HIV infection...
  22. ncbi request reprint Does hepatitis C virus infection increase the risk of HIV disease progression?
    Stephen J Rossi
    JAMA 288:241-3. 2002
  23. ncbi request reprint Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel
    Patrick G Yeni
    Hopital Bichat Claude Bernard, Department of Infectious Diseases, 46 rue Henri Huchard, Paris, Cedex 18 France 75877
    JAMA 288:222-35. 2002
    ..These updated recommendations are intended to guide practicing physicians actively involved in human immunodeficiency virus (HIV)- and acquired immunodeficiency syndrome (AIDS)-related care...
  24. ncbi request reprint The New York case: lessons being learned
    Paul A Volberding
    Ann Intern Med 142:866-8. 2005
  25. pmc Who cares for AIDS?
    Paul A Volberding
    J Gen Intern Med 17:82-3. 2002

Research Grants1

  1. UCSF-GIVI CENTER FOR AIDS RESEARCH
    Paul Volberding; Fiscal Year: 2007
    ....